澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

GENETIC SIGNATURES LTD

0.087

+0.0044.82%

成交量：12.29万

成交额：1.05万

市值：1,976.11万

市盈率：-1.77

高：0.087

开：0.085

低：0.085

收：0.083

52周最高：0.430

52周最低：0.051

股本：2.27亿

流通股本：1.88亿

量比：0.19

换手率：0.07%

股息：- -

股息率：- -

每股收益(TTM):-0.049

每股收益(LYR):-0.089

净资产收益率：-32.64%

总资产收益率：-15.95%

市净率：0.55

市盈率(LYR):-0.98

数据加载中...

总览公司新闻资讯公告

概念

新冠治疗股-1.02%

资金流向

资金流入：

资金流出：

新闻资讯

基因标记公司：合并集团有望凭借精简成本基础与潜在加速增长受益

BCAL Diagnostics将收购Genetic Signatures股份

GENETIC SIGNATURES LTD澄清：未收到亦未向ASX提交与Bcal公告相关的股份收购重大持股人通知

GENETIC SIGNATURES LTD表示无法对BCAL意图置评，仅以BCAL公告内容为准

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/hans/stock/GSS.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.087,"timestamp":1787804682572,"preClose":0.083,"halted":0,"volume":122915,"delay":0,"changeRate":0.04819277108433722,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.049055,"marketStatus":"交易中","change":0.004,"latestTime":"08-27 14:39:21 AEST","open":0.085,"high":0.087,"low":0.085,"amount":10462,"amplitude":0.024096,"askPrice":0.087,"askSize":11434,"bidPrice":0.078,"bidSize":80000,"shortable":3,"etf":0,"ttmEps":-0.049055,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787810400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.083,"openAndCloseTimeList":[[1787788800000,1787810400000]],"volumeRatio":0.185697,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"GSS.AU","preClose":0.08,"auctionPrice":0.083,"auctionVolume":215665,"auction":3,"marketStatus":"盘后竞价","timestamp":1787724586778}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-15.95%","roe":"-32.64%","lyrEps":-0.088679,"volumeRatio":0.185697,"shares":227138828,"dividePrice":0,"high":0.087,"amplitude":0.024096,"preClose":0.083,"low":0.085,"week52Low":0.051,"pbRate":"0.55","psRate":"0.97","week52High":0.43,"institutionHeld":0,"latestPrice":0.087,"committee":0.749896,"eps":-0.049055,"divideRate":0,"volume":122915,"delay":0,"ttmEps":-0.049055,"open":0.085,"prevYearClose":0.25,"prevWeekClose":0.068,"prevMonthClose":0.059,"prevQuarterClose":0.067,"fiveDayClose":0.063,"twentyDayClose":0.058,"sixtyDayClose":0.067,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787616000000,"name":null,"time":"","dateTimestamp":1787580000000,"actualEps":null},{"date":"2026-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125560310","title":"基因标记公司：合并集团有望凭借精简成本基础与潜在加速增长受益","url":"https://stock-news.laohu8.com/highlight/detail?id=1125560310","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125560310?lang=zh_cn&edition=fundamental","pubTime":"2026-08-26 07:36","pubTimestamp":1787700997,"startTime":"0","endTime":"0","summary":"基因标记公司——合并后的集团预计将从精简的成本结构中获益，并可能迎来增长加速的契机。市场分析人士指出，成本基础的收窄不仅有助于提升盈利能力，更为潜在的扩张机遇创造了有利条件。值得注意的是，合并后实体的协同效应有望在中期内逐步显现，从而推动业绩增长轨迹向上修正。简而言之，这一变革性举措预示着集团将步入一个更加精简、高效且具备增长动能的新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","MAP.AU","BK7124","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182337442","title":"BCAL Diagnostics将收购Genetic Signatures股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1182337442","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182337442?lang=zh_cn&edition=fundamental","pubTime":"2026-07-07 16:48","pubTimestamp":1783414100,"startTime":"0","endTime":"0","summary":"7月2日——BCAL Diagnostics有限公司宣布，将收购GENETIC SIGNATURES有限公司的股份。具体而言，BCAL将以139万澳元的价格，收购GENETIC SIGNATURES公司10.2%的股权。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","BK7048","BDX.AU","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183625175","title":"GENETIC SIGNATURES LTD澄清：未收到亦未向ASX提交与Bcal公告相关的股份收购重大持股人通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1183625175","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183625175?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 12:45","pubTimestamp":1782967543,"startTime":"0","endTime":"0","summary":"GENETIC SIGNATURES LTD发布澄清声明，表示公司并未收到，也未向澳大利亚证券交易所（ASX）提交任何与Bcal公告中所提及的股份收购相关的重大持股人通知。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152360294","title":"GENETIC SIGNATURES LTD表示无法对BCAL意图置评，仅以BCAL公告内容为准","url":"https://stock-news.laohu8.com/highlight/detail?id=1152360294","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152360294?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 12:42","pubTimestamp":1782967368,"startTime":"0","endTime":"0","summary":"GENETIC SIGNATURES LTD明确指出，对于BCAL的意图，除BCAL自身公告中的声明外，公司无法提供任何进一步评论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GSS.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治疗股","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":-0.010175}]}}